2015
DOI: 10.1016/j.rmcr.2014.12.001
|View full text |Cite
|
Sign up to set email alerts
|

Rescue therapy using an endobronchial valve and digital air leak monitoring in Invasive Pulmonary Aspergillosis

Abstract: In this case report, we describe the utilisation of two recently developed technologies for the successful management of a persistent air leak (PAL) in a critically ill patient in whom cardiothoracic surgical intervention was not possible. We report the case of a young leukaemic woman with a PAL complicating Invasive Pulmonary Aspergillosis (IPA), who was effectively managed using an Endobronchial Valve, supplemented by objective, digital air leak data provided by a Thopaz® device (Medela, Switzerland).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 12 publications
(11 reference statements)
0
3
0
Order By: Relevance
“…The DCS allows an objective assessment of the extent of the PAL. All of the previous studies of the use of DCS have been undertaken in the United States or Europe, 1,6,[8][9][10][11][12] and to date few has been conducted in Asia.…”
Section: Commentmentioning
confidence: 99%
See 1 more Smart Citation
“…The DCS allows an objective assessment of the extent of the PAL. All of the previous studies of the use of DCS have been undertaken in the United States or Europe, 1,6,[8][9][10][11][12] and to date few has been conducted in Asia.…”
Section: Commentmentioning
confidence: 99%
“…The safety and efficacy of this system for the management of PAL has been reported several times by investigators in the United States and Europe. [8][9][10][11] A recent multicenter international randomized comparison of DCS (using the Thopaz device) and ACS found that patients managed with a DCS experienced a shorter duration of chest tube placement, shorter hospital stay, and higher satisfaction scores compared with those managed with an ACS. 12) We anticipate that the popularity of DCS will increase globally, but note that few of the studies examining the potential therapeutic benefits of DCS have been conducted in Asia.…”
mentioning
confidence: 99%
“…The first attempt to use EBVs for the treatment of BPF was in 2005, leading to approval as a humanitarian-use device for the treatment of BPF in 2006 [7]. EBVs are introduced through the working channel of a flexible bronchoscope utilizing a unidirectional valve to prevent airflow into the diseased area of the lung resulting in the collapse of the distal lung parenchyma and attenuation of an air leak [8]. Recently, Bermea et al [9] present the largest case series for the use of EBVs as treatment for persistent air leaks, suggesting successful removal of thoracotomy tube in eighty percent of cases with only three percent of patients with device failure.…”
Section: Discussionmentioning
confidence: 99%